Skip to main content

Table 1 Risk factors, EFT, NLR, and VWF among acute ischemic stroke patients and controls

From: New stroke prognostic factors

ItemsPatients (60) No. (%)Controls (35) No. (%)Test χ2P value
Smoking19 (31.7)9 (25.7)  
No smoking41 (68.3)26 (74.3)0.380.539
Hypertension25 (41.7)12 (34.3)  
No hypertension35 (58.3)23 (65.7)0.610.477
DM20 (33.3)8 (22.9)  
No DM40 (66.7)17 (77.1)1.170.280
Hypercholesterolemia26 (43.3)7 (20.0)  
No34 (56.7)28 (80.0)5.310.021*
Hyperurecemia8 (13.3)5 (14.3)  
No52 (86.7)30 (85.7)0.020.896
BMI (≥ 25)20 (33.7)5 (14.3)  
Normal BMI(18.5–25)40 (66.7)30 (85.7)4.140.042*
AF8 (13.3)2 (5.7)  
No AF52 (86.7)33 (94.3)1.360.243
Carotid stenosis > 50%15 (25.0)2 (5.7)  
No45 (75.0)33 (94.3)5.600.018*
Combined risk > 26 (10.0)1 (2.9)  
No54 (90.0)34 (97.1)1.650.199
NLR Mean ± SD2.20 ± 1.441.43 ± 0.29t = 3.120.002**
NLR < 225 (41.7)32 (91.4)22.81< 0.001*
NLR ≥ 235 (58.3)3 (8.6)  
VWFAg (μml)10.90 ± 2.448.91 ± 1.27t = 4.48< 0.001*
EFT (Mean ± SD)1.59 ± 0.501.20 ± 0.41t = 3.87< 0.001*
EFT < 5 mm25 (41.7)28 (80.0)13.17< 0.001*
EFT ≥ 5 mm35 (58.3)7 (20.0)  
  1. Overweight and obese (BMI ≥ 25), AF atrial fibrillation, DM diabetes mellitus, NLR neutrophil/lymphocytic ratio, VWFAg vonWillbrand factor antigen, EFT epicardial fat thickness, SD standard deviation, t test student test, x2 chi square
  2. *Means highly significant, **Means significant